rs752195587

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2

The NM_001114753.3(ENG):​c.595C>T​(p.Arg199Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000884 in 1,594,262 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R199H) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00014 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000083 ( 0 hom. )

Consequence

ENG
NM_001114753.3 missense

Scores

3
16

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 1.04

Publications

0 publications found
Variant links:
Genes affected
ENG (HGNC:3349): (endoglin) This gene encodes a homodimeric transmembrane protein which is a major glycoprotein of the vascular endothelium. This protein is a component of the transforming growth factor beta receptor complex and it binds to the beta1 and beta3 peptides with high affinity. Mutations in this gene cause hereditary hemorrhagic telangiectasia, also known as Osler-Rendu-Weber syndrome 1, an autosomal dominant multisystemic vascular dysplasia. This gene may also be involved in preeclampsia and several types of cancer. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2013]
ENG Gene-Disease associations (from GenCC):
  • telangiectasia, hereditary hemorrhagic, type 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp, ClinGen
  • hereditary hemorrhagic telangiectasia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • juvenile polyposis syndrome
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.015449345).
BP6
Variant 9-127825789-G-A is Benign according to our data. Variant chr9-127825789-G-A is described in ClinVar as Benign. ClinVar VariationId is 407127.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High AC in GnomAd4 at 22 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ENGNM_001114753.3 linkc.595C>T p.Arg199Cys missense_variant Exon 5 of 15 ENST00000373203.9 NP_001108225.1
ENGNM_000118.4 linkc.595C>T p.Arg199Cys missense_variant Exon 5 of 14 NP_000109.1
ENGNM_001278138.2 linkc.49C>T p.Arg17Cys missense_variant Exon 5 of 15 NP_001265067.1
ENGNM_001406715.1 linkc.595C>T p.Arg199Cys missense_variant Exon 5 of 8 NP_001393644.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ENGENST00000373203.9 linkc.595C>T p.Arg199Cys missense_variant Exon 5 of 15 1 NM_001114753.3 ENSP00000362299.4

Frequencies

GnomAD3 genomes
AF:
0.000145
AC:
22
AN:
152116
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000724
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000131
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000848
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000118
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000176
AC:
36
AN:
205002
AF XY:
0.000160
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000324
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00154
Gnomad NFE exome
AF:
0.0000681
Gnomad OTH exome
AF:
0.000383
GnomAD4 exome
AF:
0.0000825
AC:
119
AN:
1442146
Hom.:
0
Cov.:
34
AF XY:
0.0000797
AC XY:
57
AN XY:
715620
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33154
American (AMR)
AF:
0.0000237
AC:
1
AN:
42232
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25744
East Asian (EAS)
AF:
0.00
AC:
0
AN:
38750
South Asian (SAS)
AF:
0.0000120
AC:
1
AN:
83480
European-Finnish (FIN)
AF:
0.00122
AC:
61
AN:
49850
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5544
European-Non Finnish (NFE)
AF:
0.0000489
AC:
54
AN:
1103838
Other (OTH)
AF:
0.0000336
AC:
2
AN:
59554
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
7
14
22
29
36
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000145
AC:
22
AN:
152116
Hom.:
0
Cov.:
32
AF XY:
0.000215
AC XY:
16
AN XY:
74300
show subpopulations
African (AFR)
AF:
0.0000724
AC:
3
AN:
41416
American (AMR)
AF:
0.000131
AC:
2
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5196
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4832
European-Finnish (FIN)
AF:
0.000848
AC:
9
AN:
10618
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.000118
AC:
8
AN:
67992
Other (OTH)
AF:
0.00
AC:
0
AN:
2092
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1
3
4
6
7
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000450
Hom.:
0
Bravo
AF:
0.000102
ExAC
AF:
0.0000761
AC:
9

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Hereditary hemorrhagic telangiectasia Benign:1
Sep 29, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Cardiovascular phenotype Benign:1
Sep 19, 2024
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.20
BayesDel_addAF
Benign
-0.30
T
BayesDel_noAF
Benign
-0.48
CADD
Benign
19
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.50
T;T;.
Eigen
Benign
-0.27
Eigen_PC
Benign
-0.45
FATHMM_MKL
Benign
0.27
N
LIST_S2
Benign
0.84
T;T;D
M_CAP
Benign
0.040
D
MetaRNN
Benign
0.015
T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.9
L;.;L
PhyloP100
1.0
PrimateAI
Benign
0.31
T
PROVEAN
Benign
-2.1
N;.;N
REVEL
Benign
0.071
Sift
Uncertain
0.018
D;.;D
Sift4G
Benign
0.073
T;D;T
Polyphen
1.0
D;.;.
Vest4
0.34
MutPred
0.47
Gain of catalytic residue at P198 (P = 0.0097);.;Gain of catalytic residue at P198 (P = 0.0097);
MVP
0.58
MPC
0.78
ClinPred
0.075
T
GERP RS
2.5
Varity_R
0.18
gMVP
0.52
Mutation Taster
=93/7
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs752195587; hg19: chr9-130588068; API